一种利用质谱信息进行结构特征鉴定的模式识别方法

本文提出了分段式离子系列谱编码方法,实验证明具有很好的结构表征能力。本程序主要是以模式识别技术为基础,实现了对未知物谱图的KNN分类,进而得到未知物的主要结构特征。这个程序应用于有机化合物的分类,取得了满意的结果。     

Effect of solvent composition on dispersing ability of reaction sialon suspensions

This work focuses on the optimization of the rheological behavior of suspensions considering different solvent compositions. The effects of methyl ethyl ketone (MEK)/ethanol (E) solvent mixtures on reaction sialon suspensions were investigated by measuring sedimentation behavior, adsorption of dispersant, and flow behavior. It was shown that both the flow behavior and the sedimentation behavior strongly depended on selection of solvent composition. Using 3 wt% KD1 as dispersant, well-dispersed colloidal suspensions could be obtained in MEK-rich solvents. The suspensions with 60 vol% MEK/40 vol% E as solvent could be fitted to the Bingham model with very low yield stress, while suspensions with pure MEK or ethanol-rich mixtures as solvent showed pseudo plastic behavior with relatively high yield stress values. A model was proposed to explain the different flow behaviors of suspensions considering the different configurations of dispersant at particles' surfaces.     

钙钛矿型复合氧化物Ca_xSr_（1－x）TiO_3催化剂上的甲烷氧化偶联反应

在固定床反应器上，评价了不同温度下钙钛矿型复合氧化物ＳｒＴｉＯ３和ＣａＴｉＯ３的组成变化对甲烷氧化偶联反应的影响．同时，利用ＸＰＳ和ＣＯ２－ＴＰＤ对催化剂的结构及其氧物种的反应特性进行了表征．结果表明：ＳｒＴｉＯ３和少量Ｃａ掺杂的ＣａｘＳｒｌ－ｘＴｉＯ３有利于在较低温度（９２３Ｋ）下催化反应的活性和选择性，而ＣａＴｉＯ３体系则在高温（１０７３Ｋ）下表现出较好的活性和选择性．钙钛矿型复合氧化物ＳｒＴｉＯ３和ＣａＴｉＯ３组成变化对不同温度下反应活性的影响与ＣＯ２－ＴＰＤ的脱附谱图有很好的平行关系．     

甲烷在SrO-La2O3/CaO催化剂上的氧化偶联Ⅱ.反应动力学的研究

在２０％Ｌａ２Ｏ３／ＣａＯ（ＬＣ）催化剂中添加ＳｒＯ（添加ＳｒＯ的ＬＣ以ＳＬＣ表示）明显地提高了反应活性和Ｃ２选择性。反应动力学研究表明，ＬＣ和ＳＬＣ催化剂在甲烷氧化偶联反应中，在表观活化能和表观反应级数上存在很大的差异。ＬＣ催化剂在ＣＨ４转化以及Ｃ２和ＣＯｘ形成过程中，表观活化能大于ＳＬＣ催化剂，而ＳＬＣ催化剂的指前因子小于ＬＣ体系，两者存在着补偿形象。ＳＬＣ催化剂的反应速率常数比ｋｃ２／ｋＣＨ     

Enzymatic synthesis of optically active α-chloro-δ-hydroxy-β-ketoalkanephosphonates and reactions thereof

A novel and enzymatic approach to α-chloro-δ-hydroxy-β-ketoalkanephosphonates was developed via enantioselective CALB-catalyzed acetylation and CRL-catalyzed hydrolysis. The resultant optically active compounds provide, via Horner-Wadsworth-Emmons (HWE) reaction, chiral α,β-unsaturated ketones that are building block with potential application in organic synthesis.     

A Minor New Flavone from Scutellaria baicalensis Georgi

A new flavone,6,2′-dihydroxy-5,7,8,6′-tetramethoxyflavone,was isolated from the roots of Scutellaria baicalensis. Its structure was established on the basis of spectral evidences.     

导电高分子膜包覆YBa2Cu3O7超导体抗环境作用的研究

通过电化学途径和化学途径在ＹＢａ＿２Ｃｕ＿３Ｏ＿７超导体表面制备了导电高分子聚吡咯膜，用以保护超导体不受环境作用的影响，实验结果发现电化学过程能破坏ＹＢａ＿２Ｃｕ＿Ｏ＿７的超导性，而采用化学法制备的聚吡咯和聚氯乙烯混和材料包覆在ＹＢａ＿２Ｃｕ＿３Ｏ＿７表面后，超导体不仅保持原有超导性，而且有很好的保护超导体免遭环境中酸和水作用的能力。     

High-level expression of soluble human β-defensin-2 fused with green fluorescent protein in Escherichia coli cell-free system

Human β-defensin-2 (hBD2), a small cationic peptide, exhibits a broad range of antimicrobial activity and does not acquire any microbial resistance. To produce this uneasily detectable, degradable, and toxic polypeptide efficiently, an alternative approach based on the Escherichia coli cell-free biosynthesis system was proposed. The approach implies that a polypeptide of interest is synthesized as a fusion protein linked to a green fluorescent protein (GFP) through a cleavable spacer. With batch-mode operation, a significant amount of hBD2 fused with GFP (0.25 mg/mL) can be expressed in this cell-free system. The productivity of the fusion protein can be improved up to 1.2 mg/mL by employing a continuous-exchange cell-free system. Furthermore, the GFP moiety provides directly visible and quantitative monitoring of the polypeptide synthesis, and the product is soluble and stable. This work will be helpful in allowing the rapid and visible expression of other similar defensins using an in vitro cell-free system.     

Highly efficient rhodium/monodentate phosphoramidite catalyst and its application in the enantioselective hydrogenation of enamides and alpha-dehydroamino acid derivatives

An easily prepared and highly efficient monodentate phosphoramidite ligand derived from BINOL, (S)-2,2'-O,O-(1,1'-binaphthyl)-dioxo-N,N-diethylphospholidine, was examined in the hydrogenation of both enamides and alpha-dehydroamino acid derivatives. The catalyst provided remarkably high enantioselectivities (up to 99.6% ee for enamides and >99.9% ee for alpha-dehydroamino acid derivatives).     

2-Deoxy-d-glucose Promotes Buforin IIb-Induced Cytotoxicity in Prostate Cancer DU145 Cells and Xenograft Tumors

Inhibition of the glycolytic pathway is a critical strategy in anticancer therapy because of the role of aerobic glycolysis in cancer cells. The glycolytic inhibitor 2-Deoxy-d-glucose (2-DG) has shown potential in combination with other anticancer agents. Buforin IIb is an effective antimicrobial peptide (AMP) with broad-spectrum anticancer activity and selectivity. The efficacy of combination treatment with 2-DG and buforin IIb in prostate cancer remains unknown. Here, we tested the efficacy of buforin IIb as a mitochondria-targeting AMP in the androgen-independent human prostate cancer cell line DU145. Combining 2-DG with buforin IIb had a synergistic toxic effect on DU145 cells and mouse xenograft tumors. Combination treatment with 2-DG and buforin IIb caused stronger proliferation inhibition, greater G1 cell cycle arrest, and higher apoptosis than either treatment alone. Combination treatment dramatically decreased L-lactate production and intracellular ATP levels, indicating severe inhibition of glycolysis and ATP production. Flow cytometry and confocal laser scanning microscopy results indicate that 2-DG may increase buforin IIb uptake by DU145 cells, thereby increasing the mitochondria-targeting capacity of buforin IIb. This may partly explain the effect of combination treatment on enhancing buforin IIb-induced apoptosis. Consistently, 2-DG increased mitochondrial dysfunction and upregulated Bax/Bcl-2, promoting cytochrome c release to initiate procaspase 3 cleavage induced by buforin IIb. These results suggest that 2-DG sensitizes prostate cancer DU145 cells to buforin IIb. Moreover, combination treatment caused minimal hemolysis and cytotoxicity to normal WPMY-1 cells. Collectively, the current study demonstrates that dual targeting of glycolysis and mitochondria by 2-DG and buforin IIb may be an effective anticancer strategy for the treatment of some advanced prostate cancer.